Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
about
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to TherapySWI/SNF complex in cancerRapid and reversible epigenome editing by endogenous chromatin regulatorsTOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin.Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.Chemically Controlled Epigenome Editing through an Inducible dCas9 System.A General Non-Radioactive ATPase Assay for Chromatin Remodeling Complexes.Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.Epigenetic Alterations in Bone and Soft Tissue Tumors.Epigenetic regulation in medulloblastoma.Rapid chromatin repression by Aire provides precise control of immune tolerance.Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers.Chromatin dependencies in cancer and inflammation.The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase SeparationMutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability DisordersInduction of innate immune memory via microRNA targeting of chromatin remodelling factors
P2860
Q38706007-B19C68C5-FAE6-4F50-8194-A9681FE5009BQ39433158-9B976863-BC14-4432-8828-859B81A721C3Q41686751-3857CF60-2A24-49E0-9154-6AEC374FDB3DQ41701373-2C2C2CAD-7374-4935-BDEB-D013D9695402Q42291151-9292901C-95FE-428F-ADC8-CD3469B989E2Q42378723-C823CA87-9BD3-420E-98FC-C20673558724Q45768274-E8077ADF-730C-4286-B41D-A788426E50B9Q46196399-6BF6F98C-0881-4920-9C39-9589DD00E1A6Q47133201-A133FC55-921D-4699-859F-586867DF9779Q47835503-F0070EF9-169C-4C76-BE0A-51078FA01726Q47900778-9F22A85C-403D-4F15-92BD-018A741890BEQ48239289-337C0351-11BB-4A8C-83F5-721F83E0D10EQ48262529-57670884-5D53-408D-BB18-F648319EE2A1Q49565575-44A3C878-E014-47EF-A6DE-7E94BA893946Q50420957-F65262F8-9463-4AD5-8260-CF9BA096BD9DQ57167864-EA86DB0D-DD6F-4F70-A589-7A878DDC4F1FQ58798742-6A9819D0-E409-44DD-9B70-55B79C0EE5ECQ58801736-DE9BEEEF-1CDE-4AE5-B038-058F04C09889Q59066703-58ABE9C8-B66B-450B-9233-0FA7CE93E11E
P2860
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@en
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@nl
type
label
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@en
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@nl
prefLabel
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@en
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@nl
P2093
P2860
P50
P356
P1433
P1476
Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
@en
P2093
Gerald R Crabtree
Joseph P Calarco
Wai Lim Ku
P2860
P2888
P304
P356
10.1038/NG.3735
P407
P577
2016-12-12T00:00:00Z
P6179
1026243944